Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments
Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments.
Considering Mental Health Before The New Year
As the year comes to a close, this time presents a great opportunity to think about your mental health and treatment, if applicable.
5 Things to Know About Major Depressive Disorder
Five Things to Know About Major Depressive Disorder
Clinicians Treating Patients With Depression and Substance Abuse May Find Answers With Genetic Testing
An educational webinar explores how genetic testing can help clinicians with patients dealing with those who suffer from MDD and substance use disorder.
An Eastern and Western Perspective on Personalized Medicine
Deepak Chopra, MD and Rudolph E. Tanzi, PhD discuss the history and different perspectives of personalized medicine in the Eastern and Western hemispheres.
How Personalized Medicine Changed My Life: A Patient’s Story
Genetic testing patient success story retold in the subject’s own words.
Recognition Grows for Genomind as a Leader in Genetic Testing for Mental Health Treatment
Genomind, a personalized medicine company bringing innovation to mental health care through genetic testing, continues to receive awards and recognition.
National Depression Screening Day
Depression is one of the most common mental illnesses affecting millions of adults in the U.S. Learn about early screening and why it’s important.
Americans Embrace Genetic Testing for Chronic Diseases, Yet Mental Illness Still Lags Behind Others, Survey Finds
According to the Genomind Mental Health Poll, Americans have divergent views about genetic testing for chronic diseases versus testing for mental illness.
American Opinions on Mental Illness and Genetic Testing
Through a Genomind Mental Health Poll of 1,000 we found how Americans feel about mental illness and genetic testing.
4 Things You Should Know About Bipolar Disorder
Although bipolar disorder is well known, there is a lot of misunderstanding. In recognition of Bipolar Awareness Day, here are 4 answers to common questions
Uncovering The Mental Health Crisis in Schools
Public schools are struggling to support the millions of students that deal with mental health issues everyday.
Clinicians Prepare to Learn How Genomind’s Genecept Assay® Can Help in ADHD Treatment
Genomind will present an educational webinar for clinicians interested in learning how the test can help guide personalized ADHD treatment for patients.
It’s Okay To Talk: Men Are Speaking Out About Suicide
Men have been posting the “OK” symbol with their hands with the hashtag #ItsOkayToTalk to speak out about mental health and suicide.
Mental Health Champions: Celebrities Are Speaking Out
Kristen Bell and Dax Shepard have been strong advocates for mental health and substance abuse awareness, encouraging others to join the conversation.
Why I Recommend Genetic Testing For My Patients
Genetic testing is a remarkable technologic advancement in psychiatry. Read why Dr. Bruce Kehr recommends genetic testing for his patients.
An Olympian Shares Her Struggle With Depression
For some athletes, depression can present a major problem both during the season and after they eventually retire from competition.
New Study Finds Locations in DNA Associated with Depression
A new depression study demonstrates the effect that DNA has on mental illness and depression, helping pave the way for more effective treatment.
Genomind Named One of the Best Places to Work in Healthcare
Genomind was recently named one of the best places to work in healthcare by Modern Healthcare Magazine and Best Companies Group.
Summer is Not a Time Off for ADHD Treatment
Summer can be an ideal time to diagnose and find ADHD treatment options – symptoms don’t disappear when the last school bell of the year rings.
Representative Brendan Boyle Tours the Genomind Lab
Genomind was excited to highlight the importance of the biotech industry to Pennsylvania today when Representative Brendan Boyle visited our laboratory.
Genetic Testing for ADHD Patients From Genomind Can Help Them Get Better
Summer is ideal to diagnose and treat ADHD. Clinicians who use Genomind’s Genecept Assay® say testing young patients when they aren’t in school makes sense.
Rep. Brendan Boyle Tour of Genomind Lab In King of Prussia to Showcase Personalized Medicine for Mental Health
Genomind lab will highlight the importance of the biotech industry to Pennsylvania when Representative Brendan Boyle tours its lab.
4 Things to Know About PTSD
Post-traumatic stress disorder (PTSD) is a mental health condition that is misunderstood. Here’s what veterans, women, and anyone with trauma should know.
Mental health care in the U.S.: Why is the brain treated differently than other organs?
Mental health care in the U.S.: Why is the brain treated differently than other organs?
The Importance of Genetic Testing And Why I Cofounded Genomind
In celebration of Mental Health Awareness Month, Dr. Jay Lombard explored the reason he co-founded Genomind and the future of genetic testing.
Mental Health Awareness Month Webinar
Watch our latest webinar in recognition of Mental Health Awareness Month.
Personalized Medicine 101
“Personalized medicine” is a relatively new model in the medical world. What exactly is it, and how is it affecting people today?
5 Things You Should Know About Autism Spectrum Disorder
In honor of Autism Awareness Month this April, we’ve pulled together five things you should know about autism spectrum disorder.
‘Dr. Phil’ Show to Feature Genomind’s Genecept Assay in Upcoming Program Aimed at Helping a Patient Get Better
Genomind will soon be featured in a nationally broadcast episode of “Dr. Phil”, highlighted as part of a program focused on helping a family in crisis.
